| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.474 | 22.663 | 22.818 | 23.168 | 38.015 | 33.622 | 33.179 | 24.655 | 30.665 |
| Total Income - EUR | - | 5.474 | 22.663 | 22.818 | 23.168 | 38.015 | 33.622 | 33.198 | 24.671 | 30.782 |
| Total Expenses - EUR | - | 4.130 | 13.849 | 14.648 | 18.765 | 17.960 | 14.982 | 23.680 | 15.450 | 29.228 |
| Gross Profit/Loss - EUR | - | 1.344 | 8.814 | 8.171 | 4.403 | 20.056 | 18.640 | 9.518 | 9.221 | 1.554 |
| Net Profit/Loss - EUR | - | 1.180 | 8.134 | 7.486 | 3.708 | 18.915 | 17.631 | 8.523 | 7.123 | 847 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Primavera Gyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 10.368 | 6.786 | 4.040 | 561 | 1.316 | 912 | 556 | 1.611 |
| Current Assets | - | 3.203 | 4.781 | 15.771 | 15.399 | 23.749 | 16.922 | 8.858 | 7.691 | 14.133 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.048 | 3.430 | 10.508 | 8.233 | 1.833 | 274 | 4.946 | 636 | 1.564 |
| Cash | - | 2.155 | 1.351 | 5.263 | 7.166 | 21.916 | 16.649 | 3.912 | 7.054 | 12.569 |
| Shareholders Funds | - | 1.224 | 8.187 | 15.523 | 18.930 | 18.965 | 17.981 | 8.571 | 8.002 | 8.803 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.979 | 6.962 | 7.034 | 509 | 5.346 | 257 | 1.199 | 245 | 6.941 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Primavera Gyn Srl